Amyloid in the islets of Langerhans: thoughts and some historical aspects.
about
Dynamic pathology of islet endocrine cells in type 2 diabetes: β-Cell growth, death, regeneration and their clinical implicationsLocalized AL amyloidosis: a suicidal neoplasm?Transthyretin-derived amyloidosis: probably a common cause of lumbar spinal stenosis.A binding-site barrier affects imaging efficiency of high affinity amyloid-reactive peptide radiotracers in vivoScreening and classifying small-molecule inhibitors of amyloid formation using ion mobility spectrometry-mass spectrometry.Ion mobility spectrometry-mass spectrometry defines the oligomeric intermediates in amylin amyloid formation and the mode of action of inhibitorsInsights into the consequences of co-polymerisation in the early stages of IAPP and Aβ peptide assembly from mass spectrometry.Localized amyloids important in diseases outside the brain--lessons from the islets of Langerhans and the thoracic aorta.Mechanistic Contributions of Biological Cofactors in Islet Amyloid Polypeptide Amyloidogenesis.The study of regulatory effects of Pdx-1, MafA and NeuroD1 on the activity of porcine insulin promoter and the expression of human islet amyloid polypeptide.Amylin uncovered: a review on the polypeptide responsible for type II diabetes.Further evidence for amyloid deposition in clinical pancreatic islet grafts.Understanding co-polymerization in amyloid formation by direct observation of mixed oligomers.Inhibition of peptide aggregation by means of enzymatic phosphorylation.Development of proteolytically stable N-methylated peptide inhibitors of aggregation of the amylin peptide implicated in type 2 diabetes.Extensive amyloid formation in transplanted microencapsulated mouse and human islets.
P2860
Q26752746-12804896-C0C3-4AB3-8D5D-6A6E5D829452Q27692643-FE966671-D651-4D08-950F-C67C5B7D5FD9Q33978484-A7652CD8-8E27-4AC0-B170-0F23CB27A46EQ34764389-311C03DA-59CA-4250-A5F3-A60F5EFA0E85Q34792888-DF4B95DB-F997-4DB3-AA7A-C3AE09162611Q35076599-8458CE0A-1024-4029-B2BC-217A4ED8734FQ36224635-25590515-D808-4BDE-86B9-0C85E2927C64Q37915629-AA045598-5D7A-4CB4-B63C-6A4A7956ABB8Q38635739-282EC09D-FF27-481C-BD24-8720EC0039DDQ38995270-9D2F821A-C824-4C80-8F71-BDF5ABBBA31BQ39846208-1AAE982F-CFB0-4F7E-B1BD-65B1F8AA94AEQ41623363-ED13386E-AC4A-4AE6-B866-D676BFB3BDF2Q41774231-4527A4DC-7804-4628-8D6A-4E4AD7BD2557Q42330245-12E5E181-F008-4914-9EFF-8BA277A32254Q48286557-FD2BF075-403A-4300-AFB8-A8A6CEDDBE10Q50510994-9AD1264C-57E5-43B2-B5A4-165366E711CE
P2860
Amyloid in the islets of Langerhans: thoughts and some historical aspects.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Amyloid in the islets of Langerhans: thoughts and some historical aspects.
@en
Amyloid in the islets of Langerhans: thoughts and some historical aspects.
@nl
type
label
Amyloid in the islets of Langerhans: thoughts and some historical aspects.
@en
Amyloid in the islets of Langerhans: thoughts and some historical aspects.
@nl
prefLabel
Amyloid in the islets of Langerhans: thoughts and some historical aspects.
@en
Amyloid in the islets of Langerhans: thoughts and some historical aspects.
@nl
P2860
P921
P1476
Amyloid in the islets of Langerhans: thoughts and some historical aspects.
@en
P2093
Per Westermark
P2860
P356
10.3109/03009734.2011.573884
P577
2011-05-01T00:00:00Z